Correlation Between Alnylam Pharmaceuticals and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Ultragenyx, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Ultragenyx.
Diversification Opportunities for Alnylam Pharmaceuticals and Ultragenyx
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alnylam and Ultragenyx is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Ultragenyx go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Ultragenyx
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to under-perform the Ultragenyx. In addition to that, Alnylam Pharmaceuticals is 1.23 times more volatile than Ultragenyx. It trades about -0.23 of its total potential returns per unit of risk. Ultragenyx is currently generating about -0.21 per unit of volatility. If you would invest 5,307 in Ultragenyx on August 27, 2024 and sell it today you would lose (583.00) from holding Ultragenyx or give up 10.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Ultragenyx
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Ultragenyx |
Alnylam Pharmaceuticals and Ultragenyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Ultragenyx
The main advantage of trading using opposite Alnylam Pharmaceuticals and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |